Evaluation of Performance and Safety of Eye Drops With Hydroxypropyl-methylcellulose and Inositol in Drye Eye Disease

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2024

Conditions
Dry Eye Disease Associated to Asthenopia and Accommodative Effort in Video Display Terminal Users
Interventions
DEVICE

MERAMIRT

"MERAMIRT®, a class IIa medical device, is indicated for hydration and lubrication of the ocular surface under conditions of eye disorders caused by environmental, visual and mechanical stress, also due to asthenopia and accommodation effort. The main component of MERAMIRT® are Hydroxypropyl-methylcellulose (HPMC 0.3%) and Inositol (0.1%).~HPMC has the property of moisturizing and lubricating the eye. Inositol is used with an antioxidant role"

Trial Locations (4)

24020

RECRUITING

ASST Bergamo Est-Ospedale M.O.A. Locatelli, Piario

84131

RECRUITING

AOU- San Giovanni di Dio e Ruggi d'Aragona, Salerno

00128

NOT_YET_RECRUITING

Fondazione Policlinico Universitario Campus Biomedico, Roma

01100

RECRUITING

Ospedale Bel Colle, Viterbo

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY